evans blue has been researched along with salmeterol xinafoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, MJ; Coleman, RA | 1 |
| Baluk, P; Gómez, AD; Hashizume, H; Kwan, ML; McDonald, DM | 1 |
2 other study(ies) available for evans blue and salmeterol xinafoate
| Article | Year |
|---|---|
Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albumins; Albuterol; Analysis of Variance; Animals; Capillary Permeability; Catechols; Cattle; Cells, Cultured; Dioxoles; Dose-Response Relationship, Drug; Endothelium, Vascular; Evans Blue; Hydrogen Peroxide; Isoproterenol; Lipopolysaccharides; Nitroprusside; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P.
Topics: Albuterol; Animals; Bronchodilator Agents; Capillary Permeability; Chronic Disease; Dose-Response Relationship, Drug; Drug Hypersensitivity; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Indoles; Male; Mycoplasma Infections; Organ Size; Organometallic Compounds; Platelet Activating Factor; Rats; Rats, Inbred F344; Rats, Wistar; Salmeterol Xinafoate; Serotonin; Species Specificity; Specific Pathogen-Free Organisms; Substance P; Trachea | 2001 |